http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA05013146-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e0d6432f5b9600d394f4b154c2d89fe
publicationDate 2006-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-PA05013146-A
titleOfInvention DERIVATIVES OF ANILINA.
abstract This invention relates to compounds of the formula (see formula I) wherein X, Y, R1 to R11 and n are as defined in the description, and all pharmaceutically acceptable enantiomers and salts and / or esters thereof. The invention also relates to pharmaceutical compositions containing such compounds, a process for their preparation and their use for the treatment and / or prevention of diseases that are modulated by PPAR (and / or PPAR agonists).
priorityDate 2003-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5465
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID374120
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403654
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25747
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID458910
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID557714
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997

Total number of triples: 44.